Dyne Therapeutics (DYN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec16

Stifel Nicolaus analyst maintains buy rating on Dyne Therapeutics

08:17

Dec13

TFG Asset Management GP Acquired Dyne Therapeutics Inc. Stock in Q2

13:38

Dec11

Dyne Therapeutics Completes IPO Raising $402.5 Million

21:28

Dec10

Dyne Therapeutics Offering 18.98 Million New Shares

07:17

Dec9

Chardan Capital Reiterates Buy Rating for Dyne Therapeutics

13:54

Dec8

Dyne Therapeutics Launches $300 Million Common Stock Firm Offering

21:23

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -108.04 M, EPS -0.7618

Jul28

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -110.86 M, EPS -0.9735

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -115.36 M, EPS -1.0495

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More